Vall d-Hebron Institut d'Oncologia

Barcelona 8035

2 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Cancer, Cervical Cancer, Chondrosarcoma, Chronic Lymphocytic Leukemia, Colorectal Cancer, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Endometrioid Adenocarcinoma, Fallopian Tube Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs — Recruiting now
• A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors — Recruiting now
• Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers — Completed
• A Study of AGEN2034 in Advanced Tumors and Cervical Cancer — Completed
• SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas — Completed
• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers — Stopped early
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia — Completed